Form 4: Procept BioRobotics Director Antal Desai Reports Share Distributions

Director Antal Rohit Desai reports pro rata distributions of Procept BioRobotics Corp shares from investment partnerships and trusts, with no consideration involved.

Summary

• Antal Rohit Desai, a director at Procept BioRobotics Corp, filed a Form 4 detailing changes in beneficial ownership.
• The report covers transactions that occurred on May 20, 2024.
• Shares were distributed on a pro rata basis from White Tailed Ptarmigan, LP and Mallard Fund, L.P., for no consideration.
• These distributions are exempt from Section 16 under Rules 16a-9 and 16a-13.
• Desai disclaims beneficial ownership of shares held by CPMG Funds and The 2:22 DNA Trust, except to the extent of any pecuniary interest.
• White Tailed Ptarmigan, LP distributed 1,949,104 shares, including 163,030 shares in exempt transactions, resulting in Desai indirectly owning 711,547 shares.
• Mallard Fund, L.P. distributed 164,063 shares, including 37 shares in exempt transactions, resulting in Desai indirectly owning 180,527 shares.
• Desai also indirectly owns 66,260 shares through Kestrel Fund, L.P. and 367,035 shares through The 2:22 DNA Trust.
• Desai directly owns 57,807 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share distributions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.

Positives

• The pro rata distributions do not represent a sale or disposal of shares for value, indicating no negative sentiment from the reporting person.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The pro rata distributions may have a minor impact on shareholders due to the change in ownership structure, but the impact is likely minimal as there was no consideration involved.

Key Dates